Kenneth A. Burdick, a director of LifeStance Health Group, Inc., filed a Form 144 notice on November 10, 2026, disclosing a proposed sale of 75,000 shares of common stock following a stock option exercise.

Key Highlights

  • Proposed sale: Kenneth A. Burdick, listed as a Director, intends to sell 75,000 shares of LifeStance Health Group common stock.
  • Aggregate market value: The 75,000 shares carry an aggregate market value of $1,095,081.98, according to the filing.
  • Source of shares: The securities were acquired on November 10, 2026, through a stock option exercise from the issuer, with payment made in cash.
  • Approximate sale date: The filing lists November 10, 2026, as the approximate date of sale, with Fidelity Brokerage Services LLC named as broker.
  • Shares outstanding: The filing reports 380,190,724 shares of common stock outstanding.
  • Prior sales in past 3 months: Burdick sold 500,000 shares on August 11, 2026, for gross proceeds of $5,756,737.55, and 66,589 shares on November 9, 2026, for gross proceeds of $959,715.86.

Burdick's Proposed Stock Sale and Recent Transaction History at LifeStance Health

According to the Form 144 filing dated November 10, 2026, Kenneth A. Burdick, a director of LifeStance Health Group, Inc. (NASDAQ:LFST), notified the SEC of a proposed sale of 75,000 shares of the company's common stock. The filing identifies Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, as the named broker for the transaction. The aggregate market value of the shares to be sold is listed as $1,095,081.98.

The filing discloses that the 75,000 shares were acquired on November 10, 2026, via a stock option exercise from the issuer, with the date of payment also listed as November 10, 2026, and the nature of payment described as cash. The company is headquartered at 4800 N. Scottsdale Road, Suite 2500, Scottsdale, Arizona 85251, and had 380,190,724 shares of common stock outstanding as of the filing date.

As required by Rule 144, the filing also discloses Burdick's sales of company common stock over the prior three months. On August 11, 2026, he sold 500,000 shares with gross proceeds of $5,756,737.55. On November 9, 2026, he sold an additional 66,589 shares with gross proceeds of $959,715.86. The filing was signed by Gary Redman, described as "a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kenneth Burdick."

What Was Disclosed

LifeStance Health Group director Kenneth A. Burdick filed a Form 144 on November 10, 2026, proposing the sale of 75,000 shares of common stock, valued at $1,095,081.98, following a stock option exercise. The filing also disclosed two prior sales totaling 566,589 shares in the preceding three months.